| Title |
Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia
|
|---|---|
| Published in |
Cancer Discovery, May 2021
|
| DOI | 10.1158/2159-8290.cd-20-1793 |
| Pubmed ID | |
| Authors |
Leonie Smeenk, Sophie Ottema, Roger Mulet-Lazaro, Anja Ebert, Marije Havermans, Andrea Arricibita Varea, Michaela Fellner, Dorien Pastoors, Stanley van Herk, Claudia Erpelinck-Verschueren, Tim Grob, Remco M. Hoogenboezem, François G. Kavelaars, Daniel R. Matson, Emery H. Bresnick, Eric M. Bindels, Alex Kentsis, Johannes Zuber, Ruud Delwel |
X Demographics
The data shown below were collected from the profiles of 45 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 15 | 33% |
| Austria | 2 | 4% |
| Netherlands | 2 | 4% |
| United Kingdom | 2 | 4% |
| Germany | 1 | 2% |
| France | 1 | 2% |
| Norway | 1 | 2% |
| Brazil | 1 | 2% |
| Japan | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 16 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 23 | 51% |
| Scientists | 16 | 36% |
| Science communicators (journalists, bloggers, editors) | 4 | 9% |
| Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 27% |
| Student > Master | 8 | 16% |
| Student > Bachelor | 7 | 14% |
| Researcher | 6 | 12% |
| Student > Doctoral Student | 1 | 2% |
| Other | 5 | 10% |
| Unknown | 9 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 22 | 45% |
| Medicine and Dentistry | 6 | 12% |
| Agricultural and Biological Sciences | 4 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Unspecified | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 12 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2022.
All research outputs
#1,492,236
of 25,623,883 outputs
Outputs from Cancer Discovery
#729
of 4,087 outputs
Outputs of similar age
#38,701
of 455,824 outputs
Outputs of similar age from Cancer Discovery
#49
of 130 outputs
Altmetric has tracked 25,623,883 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,087 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 130 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.